Proseek Bio
PrivateLast Round
Seed
Apr 8, 2026
Total Funding Raised
$1.06M
Company Overview
Proseek Bio operates in Healthcare & Life Sciences and is based in Brisbane. Its latest recorded funding round was a Seed round in April 2026.
Proseek Bio is a biotechnology company that develops non-invasive, multi-biomarker blood tests for women's health, focusing on early detection of ovarian cancer using a proprietary glycoproteomics mass spectrometry platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proseek Bio Comparables
Compare Proseek Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyOncoDx, Inc. | 84% | |
| InterVenn Biosciences | 84% | |
| CpG Diagnostics, Inc. | 83% |
For institutional investors. Book with your work email.
Proseek Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Proseek Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scale Investors | Seed |
| Angel Loop | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Grew 57% QoQ from 7 to 11 employees.
- Apr 9, 2026
Grew 67% QoQ, from 6 to 10 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 2, 2026
Proseek Bio Pty Limited announces that Kirsty Garrett has joined as Board Chair.
- hiresSep 4, 2026
Proseek Bio Pty Limited hires Dr. David Herold, MD, PhD, as its first Clinical Advisor, bringing decades of clinical pathology and mass spectrometry expertise to its advisory board as it develops a blood test for suspicious ovarian masses.
For institutional investors. Book with your work email.
Proseek Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proseek Bio's valuation, stock price, and market status.
Is Proseek Bio a public or private company?
Proseek Bio is a private company.
What is the current stock price of Proseek Bio?
Proseek Bio is a private company, so its shares have no public market price. Caplight tracks Proseek Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proseek Bio worth (valuation)?
Valuation information for Proseek Bio is not publicly available.
Can I buy Proseek Bio stock?
Proseek Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proseek Bio's last funding round?
Proseek Bio's most recent funding round was Seed on April 8, 2026.
Who are the main investors in Proseek Bio?
Key investors in Proseek Bio include Scale Investors, Angel Loop.
Will Proseek Bio IPO soon?
No public IPO plans have been announced for Proseek Bio.
How can I track Proseek Bio secondary market activity?
Caplight tracks bids, offers, and trades in Proseek Bio's shares on secondary markets.